Column GROUP Iii, L.P., 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 36,790 shares at $17.97 ($661K) on 2020-08-21, disclosed to the SEC on 2020-08-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.97 | 7,321 | $132K | 19.9% |
| 2 | $17.97 | 7,321 | $132K | 19.9% |
| 3 | $17.96 | 11,024 | $198K | 30.0% |
| 4 | $17.96 | 11,024 | $198K | 30.0% |
| 5 | $18.00 | 100 | $2K | 0.3% |
| Total | $17.96 avg | 36,790 |
| $661K |
| 100% |
| Filing → |
| TNYA | BUY | 2023-03-14 | $18K | — | Filing → |
| NGM | BUY | 2023-01-23 | $191K | — | Filing → |
| TNYA | BUY | 2022-11-23 | $50.0M | — | Filing → |